reconstituting ghk cu 50 mg GHK-CU 50mg GHK-Cu | Research Peptide |

Most long-term protocols settle at 12 mg per day because the doseresponse curve plateaus

Bioavailability following subcutaneous injection is estimated at approximately 80%, substantially higher than oral administration, where peptide degradation in the gastrointestinal tract limits systemic exposure

Not all sites on the body provide equal access to this layer or equal comfort during injection

Common preservative systems for peptide formulations include phenoxyethanol, potassium sorbate, or commercially available broad-spectrum preservative blends

Contraindications GHK-Cu peptide therapy may not be suitable for individuals who: Have known hypersensitivity to copper peptides Are pregnant or breastfeeding without medical clearance Have active skin infections at the application or injection site A consultation is required to determine suitability

The copper peptide GHK-Cu has a number of biological functions in humans, including stimulation of wound healing, nerve regeneration and potential hair growth [2]